Skip to main content

2023 IKCS: Europe Main banner

Tweets by 2023 IKCS: Europe

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

R
19
Real World Experience (RWE) of Ipilimumab and Nivolumab compared to Pembrolizumab and Axitinib in Advanced Renal Cell Carcinoma (RCC)
Real-World Evidence

Favorite
28
Real world experience of managing immunotherapy toxicity at a UK tertiary centre
Treatment Toxicities and Symptom Management

Favorite
24
Real-world outcomes of nivolumab (NIVO) + ipilimumab (IPI) in patients with previously untreated clear cell advanced renal cell carcinoma (aRCC) in France.
Real-World Evidence

Favorite
21
Real-world recurrence patterns in Danish renal cell carcinoma patients
Real-World Evidence

Favorite
38
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): a multi-arm phase II trial testing reduced intensity immunotherapy across different cancers
Other

Favorite
35
Renal cell carcinoma and therapeutic opportunities in the paradigm shift – a case report
Survivorship

Favorite
23
Role of cytoreductive nephrectomy in metastatic RCC, single institution experience
Real-World Evidence

Favorite